Vol 13, No 12 (December 31, 2024): Translational Lung Cancer Research

Original Article

Anatomic and clinical implications of venous drainage variations in superior segment resections for clinical T1N0 non-small cell lung cancer
Chengyu Bian, Chenghao Fu, Wentao Xue, Yan Gu, Hongchang Wang, Wenhao Zhang, Guang Mu, Mei Yuan, Liang Chen, Qianyun Wang, Jun Wang
A novel bioassay reflecting response to immune checkpoint inhibitor therapy in non-small cell lung cancer with malignant pleural effusion
Ayako Takigami, Naoko Mato, Koichi Hagiwara, Makoto Maemondo
Successful long-term outcome of neoadjuvant sequential targeted therapy and chemotherapy for stage III non-small cell lung carcinoma: 10 case series
Masaya Aoki, Ryo Miyata, Go Kamimura, Shoichiro Morizono, Takuya Tokunaga, Aya Harada-Takeda, Koki Maeda, Toshiyuki Nagata, Kazuhiro Ueda
Health-related quality of life analysis from ENTER, a randomized, controlled phase III trial of whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases
Fei Tang, Jingyi Zhang, Zaicheng Xu, Yu Zhang, Xiaoyue Zhang, Yuan Peng, Zhenzhou Yang
Radiomicsmetabolic signature profiles for advanced non-small cell lung cancer with chemoimmunotherapy by reflecting biological function and survival
Yuxin Jiang, Tao Liu, Ke Xu, Wanjun Lu, Qinpei Cheng, Jingyuan Xie, Mo Chen, Xiangyu Bian, Tangfeng Lv, Jiang Wu, Yong Song, Ping Zhan
Quantitative peripheral live single T-cell dynamic polyfunctionality profiling predicts lung cancer checkpoint immunotherapy treatment response and clinical outcomes
Zuan-Fu Lim, Xiaoliang Wu, Lin Zhu, Heidar Albandar, Maria Hafez, Chenchen Zhao, Mohammed Almubarak, Matthew Smolkin, Hong Zheng, Sijin Wen, Patrick C. Ma
Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective study
Jialong Li, Youyu Wang, Zerui Zhao, Sihua Wang, Wanpu Yan, Xiaohui Chen, Tianxiang Chen, Pengfei Li, Sheng Wang, Qiang Fang, Lin Peng, Yongtao Han, Jian Tang, Xuefeng Leng
Development and validation of a nomogram for predicting visceral pleural invasion in patients with early-stage non-small cell lung cancer
Qinyue Luo, Hanting Li, Xiaoqing Liu, Yuting Zheng, Tingting Guo, Jun Fan, Na Wang, Xiaoyu Han, Heshui Shi
A non-interventional biomarker study in patients with adenocarcinoma of the lung treated with nintedanib plus docetaxel following progression on chemotherapy and/or immunotherapy: LUME-BioNIS
Martin Reck, Konstantinos Syrigos, Skaidrius Miliauskas, Susan C. van’t Westeinde, Bartomeu Massuti, Hannes Buchner, Alexey V. Salnikov, Robert M. Lorence, Anne-Marit Ellingboe, Thomas Kitzing, Keith Kerr
Efficacy, safety, and quality of life of dabrafenib plus trametinib treatment in Chinese patients with BRAFV600E mutation-positive metastatic non-small cell lung cancer
Yun Fan, Jianying Zhou, Yuanyuan Zhao, Yan Yu, Nong Yang, Juan Li, Jialei Wang, Jun Zhao, Zhehai Wang, Jun Chen, Tong Zhu, Haifu Li, Vanessa Q. Passos, Denise Bury-Maynard, Li Zhang
A prognostic nomogram of non-small cell lung cancer based on tumor marker inflammatory nutrition score
Yan Feng, Han Qiao, Xiaolei Han, Huaping Tang
Construction of a neutrophil extracellular trap formation-related gene model for predicting the survival of lung adenocarcinoma patients and their response to immunotherapy
Yuan Wang, Shuang Liang, Qian Hong, Juwei Mu, Yuxin Wu, Kexin Li, Yiling Li, Yue Wu, Xiaoying Lou, Danfei Xu, Wei Cui
Inhibition of miR-9-3p facilitates ferroptosis by activating SAT1/p53 pathway in lung adenocarcinoma
Anqi Wu, Anping Zhang, Tianyi Wang, Jianle Chen, Jiahai Shi
Prediction of early lung adenocarcinoma spread through air spaces by machine learning radiomics: a cross-center cohort study
Cong Liu, Ao Meng, Xiu-Qing Xue, Yu-Feng Wang, Chao Jia, Da-Peng Yao, Yun-Jian Wu, Qian Huang, Ping Gong, Xiao-Feng Li
A retrospective study of the efficacy and safety of immune checkpoint inhibitors combined with chemotherapy for the treatment of SMARCA4-deficient thoracic tumors
Bin Wang, Heng You, Dongfan Ye, Yuanyue Yi, Yu Liu, Bin Qing, Chuangye Wang, Jincheng Liu, Jian Zhang, Nanbo Wang, Pengfei Wan, Linlin Shen, Zhi Xu
Effectiveness of artificial intelligence for detecting operable lung cancer on chest radiographs
Hyun Joo Shin, Se Hyun Kwak, Kyeong Yeon Kim, Na Young Kim, Kyungsun Nam, Young Jin Kim, Eun-Kyung Kim, Young Joo Suh, Eun Hye Lee
Performance of deep learning model and radiomics model for preoperative prediction of spread through air spaces in the surgically resected lung adenocarcinoma: a two-center comparative study
Xiang Wang, Chao Ma, Qinling Jiang, Xuebin Zheng, Jun Xie, Chuan He, Pengchen Gu, Yanyan Wu, Yi Xiao, Shiyuan Liu
EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAFV600E mutation: a multi-center real-world experience in China
Wenyue Yang, Xiangran Feng, Jian Ni, Xin Zhang, Hui Yu, Xianghua Wu, Huijie Wang, Xinmin Zhao, Zhihuang Hu, Bo Yu, Yao Zhang, Ying Lin, Yi Xiang, Jialei Wang
Long-term high fat diet aggravates the risk of lung fibrosis and lung cancer: transcriptomic analysis in the lung tissues of obese mice
Jihyun Park, Danbi Jo, Seo Yoon Choi, Sumin Oh, Yoon Seok Jung, Oh Yoen Kim, Juhyun Song
Validation of T stage classification strategy for >2 cm ground-glass opacity non-small cell lung cancer: a retrospective cohort study
Yiming Li, Zhenyu Yang, Hui Jie, Liying Zhang, Chenglin Guo, Chengwu Liu, Qiang Pu, Lunxu Liu
Characteristics of the immune microenvironment and their clinical significance in lung adenocarcinoma patients with different ALK fusion variants
Yinbo Xiao, Hao Wang, Junliang Lu, Junyi Pang, Shiyi Liu, Yang Zhou, Xiaohua Shi, Zhiyong Liang
Spontaneous ventilation video-assisted thoracoscopic surgery for octogenarian non-small cell lung cancer patients: a non-inferiority study
Yulin Zhao, Xuanzhuang Lu, Runchen Wang, Keyao Dai, Huiwen Yu, Chongde Pan, Jiaqin Zhang, Xianzhe Fan, Yanwei Lin, Hengrui Liang, Jianxing He, Wei Wang, Lan Lan
Enhancing the prediction of KRAS mutation status in Asian lung adenocarcinoma: a comprehensive approach combining clinical, dual-energy spectral computed tomography, and radiomics features
Jing-Wen Ma, Cai-Xing Yuan, Shan Muhammad, Yan-Mei Wang, Lin-Lin Qi, Jiu-Ming Jiang, Xu Jiang, Lei Miao, Meng-Wen Liu, Xin Liang, Tian Qiu, Li Zhang, Meng Li
Machine learning-based radiomics for guiding lymph node dissection in clinical stage I lung adenocarcinoma: a multicenter retrospective study
Hao Zhang, Yuan Li, Sikai Wu, Yue Peng, Yang Liu, Shugeng Gao
Discrepancies in PD-L1 expression, lymphocyte infiltration, and tumor mutational burden in non-small cell lung cancer and matched brain metastases
Yanhui Zhang, Runfen Cheng, Tingting Ding, Jianghua Wu
Radiotherapy for oligoprogressive disease in non-small cell lung cancer treated with pembrolizumab in first-line setting: a retrospective study
Camille Santonja, Paul Gougis, Elise Dumas, Camille Rolland Debord, Patrick Merle, Aurélie Belliere, Luca Campedel, Baptiste Abbar
Quantitative evaluation of accumulated and planned dose deviations in patients undergoing gated and non-gated lung stereotactic body radiation therapy patients: a retrospective analysis
Shuangyan Yang, Bin Su, Hui Liu
Prognostic value of ground-glass opacity on computed tomography for patients with pathological stage IA3 lung adenocarcinoma: a multicenter retrospective cohort study
Chao Chen, Shao-Jun Xu, Xiao-Qiang Du, Jia-Hua Tu, Ren-He Yan, Hui Chen, Duilio Divisi, Sang-Won Um, Yun-Fan Luo, Zhi-Fan Zhang, Cheng-Xiong You, Shao-Bin Yu, Shu-Chen Chen
Development of an AI model for predicting hypoxia status and prognosis in non-small cell lung cancer using multi-modal data
Lina Zhou, Chenkai Mao, Tingting Fu, Xiao Ding, Luca Bertolaccini, Ao Liu, Junjun Zhang, Shicheng Li
Identification and validation of pyroptosis patterns with a novel quantification system for the prediction of prognosis in lung squamous cell carcinoma
Xianyu Qin, Jiayan Wu, Fei Qin, Yuzhen Zheng, Junguo Chen, Zui Liu, Jian Tan, Weijie Cai, Shiyun He, Bozhu Jian, Haosheng Zheng, Hongying Liao
Efficacy and safety of consolidative thoracic radiotherapy after first-line chemoimmunotherapy in patients with extensive-stage small-cell lung cancer: a retrospective cohort study
Lin Zheng, Yang Yang, Fan Bu, Ruizhi Ye, Fengming Zhang, Zhixiang Ji, Xirong Zhu, Hong Chen, Rongjun Shao, Lidan Liu, Xixi Ying, Lingying Zhu, Enyu Wang, Jifeng Feng, Zhiyong Shi, Jun Fang, Yuezhen Wang, Zhirui Zhou, Guangxian You

Review Article

Fuel for thought: targeting metabolism in lung cancer
Jaime L. Schneider, SeongJun Han, Christopher S. Nabel
Emerging insights into STK11, KEAP1 and KRAS mutations: implications for immunotherapy in patients with advanced non-small cell lung cancer
Magdalena Knetki-Wróblewska, Kamila Wojas-Krawczyk, Paweł Krawczyk, Maciej Krzakowski
Impact of lymph node involvement in pulmonary carcinoids: a narrative review
Michał Dziedzic, Marcin Cackowski, Maciej Pawlica, Zuzanna Gabrysz, Krzysztof Gofron, Tomasz Marjański
Lung cancer organoid-based drug evaluation models and new drug development application trends
Eunyoung Lee, Sang-Yun Lee, Yu-Jeong Seong, Bosung Ku, Hyeong Jun Cho, Kyuhwan Kim, Yongki Hwang, Chan Kwon Park, Joon Young Choi, Sung Won Kim, Seung Joon Kim, Jeong Uk Lim, Chang Dong Yeo, Dong Woo Lee
Mapping the evolution and frontiers of Translational Lung Cancer Research: a bibliometric analysis and literature review
Chong Li, Anqi He, Jing Hu, Yong Xia, Chengqi He, Weihua Zhuang
The current landscape and prospects of antibody-drug conjugates for lung cancer brain metastases: a narrative review
Hongxia Zhou, Yi Zeng, Toyoaki Hida, Robert Hsu, Yu Huang, Xiaorong Dong